LONDON, March 16 (Reuters) - Danish drugmaker Novo Nordisk (NOVOb.CO), opens new tab has been suspended from the Association of the British Pharmaceutical Industry (ABPI) for two years over what the ...
Processing times for complaints against drug companies suspected of having breached their industry code of practice have more than tripled in a nearly two-decade period, an investigation by The BMJ ...
Amid its two-year suspension from the Association of the British Pharmaceutical Industry, the U.K.’s pharma trade group, following a series of breaches of the organization’s code of practice, Novo ...
A U.K. pharma trade group suspended Novo Nordisk’s membership for two years after marketing efforts for its obesity drug were deemed a breach of the group’s standards. ABPI said it took the action ...
Processing times for complaints against drug companies suspected of having breached their industry code of practice have more than tripled in a nearly two-decade period, an investigation by The BMJ ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results